A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age

Clinical trial NCT07105722 · COMPLETED

Trial details

NCT number: NCT07105722
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumonia, Bacterial

Start date: 2025-08-12
Primary completion: 2026-05-06
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.